These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11501613)

  • 1. Novel role for alpha1-adrenergic receptor subtypes in lower urinary tract symptoms.
    Schwinn DA
    BJU Int; 2000 Oct; 86 Suppl 2():11-20; discussion 20-2. PubMed ID: 11501613
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms.
    Schwinn DA
    BJU Int; 2001 Sep; 88 Suppl 2():27-34; discussion 49-50. PubMed ID: 11589667
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.
    Roehrborn CG; Schwinn DA
    J Urol; 2004 Mar; 171(3):1029-35. PubMed ID: 14767264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha1-adrenergic receptors in the lower urinary tract and vascular bed: potential role for the alpha1d subtype in filling symptoms and effects of ageing on vascular expression.
    Schwinn DA; Michelotti GA
    BJU Int; 2000 Apr; 85 Suppl 2():6-11. PubMed ID: 10781179
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pharmacology of human alpha1-adrenergic receptors: unique features of the alpha 1a-subtype.
    Schwinn DA; Price RR
    Eur Urol; 1999; 36 Suppl 1():7-10. PubMed ID: 10393466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of alpha1-adrenoreceptor antagonists in the treatment of lower urinary tract symptoms.
    Andersson KE
    BJU Int; 2000 Apr; 85 Suppl 2():12-8. PubMed ID: 10781180
    [No Abstract]   [Full Text] [Related]  

  • 8. Storage and voiding symptoms: pathophysiologic aspects.
    Andersson KE
    Urology; 2003 Nov; 62(5 Suppl 2):3-10. PubMed ID: 14662401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.
    Sugaya K; Nishijima S; Miyazato M; Ashitomi K; Hatano T; Ogawa Y
    Neurosci Lett; 2002 Aug; 328(1):74-6. PubMed ID: 12123863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
    Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC
    Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region.
    Hennenberg M; Tamalunas A; Wang Y; Keller P; Schott M; Strittmatter F; Herlemann A; Yu Q; Rutz B; Ciotkowska A; Stief CG; Gratzke C
    Eur J Pharmacol; 2017 May; 803():39-47. PubMed ID: 28315343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha1-Adrenoceptor subtype selectivity and lower urinary tract symptoms.
    Schwinn DA; Price DT; Narayan P
    Mayo Clin Proc; 2004 Nov; 79(11):1423-34. PubMed ID: 15544022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action for α
    Hattori T; Sugaya K
    Life Sci; 2017 Dec; 191():90-96. PubMed ID: 29032116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of alpha1-adrenoceptor subtypes in benign prostatic hyperplasia-from bed to bench].
    Kojima Y; Hayase M; Imura M; Okada S; Kubota Y; Sasaki S; Hayashi Y; Kohri K
    Hinyokika Kiyo; 2008 Jun; 54(6):457-62. PubMed ID: 18634446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of voiding and storage reflexes by activation of alpha1-adrenoceptors.
    de Groat WC; Yoshiyama M; Ramage AG; Yamamoto T; Somogyi GT
    Eur Urol; 1999; 36 Suppl 1():68-73. PubMed ID: 10393477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenoceptor pharmacology: urogenital applications.
    Ruffolo RR; Hieble JP
    Eur Urol; 1999; 36 Suppl 1():17-22. PubMed ID: 10393468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential mechanisms of action of superselective alpha(1)-adrenoceptor antagonists.
    Price D
    Eur Urol; 2001; 40 Suppl 4():5-11. PubMed ID: 11786674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?
    Sarma AV; Parsons JK; McVary K; Wei JT
    J Urol; 2009 Dec; 182(6 Suppl):S32-7. PubMed ID: 19846144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha1- and alpha2-adrenoceptors in BPH.
    Takeda M; Hatano A; Arai K; Obara K; Tsutsui T; Takahashi K
    Eur Urol; 1999; 36 Suppl 1():31-4; discussion 65. PubMed ID: 10393470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.
    Michel MC; Vrydag W
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S88-119. PubMed ID: 16465187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.